Costa, L., Bal, S., Godby, K., Ravi, G., Medvedova, E., Callander, N., Silbermann, R., Dholaria, B., Huls, F., Mullinax, B., Joiner, L., Hagedorn, C., Dhakal, B. (2025). Redefining function high-risk (FHR) multiple myeloma (MM) in the context of upfront quadruplet (QUAD) therapy and autologous stem cell transplantation (ASCT). Blood. https://doi.org/10.1182/blood-2025-1037